5. Corneal Pathologies

Total Page:16

File Type:pdf, Size:1020Kb

5. Corneal Pathologies PERIPHERAL CORNEAL THINNING AND ULCERATION Corneal Pathologies 1. Without systemic disease • Dellen • Terrien marginal degeneration Dr. Pradeep Bastola • Mooren ulcer MD, Ophthalmologist Assistant Professor 2. With systemic disease 15th June, 2011 • Rheumatoid arthritis • Wegener granulomatosis • Polyarteritis nodosa • Common and unilateral Dellen • Innocuous Terrien marginal degeneration • Uncommon, bilateral but asymmetrical Signs Causes • Initially asymptomatic Progression • Saucer-like thinning with intact epithelium• Causes - chemosis, raised limbal lesions, • Fine stromal lipid deposition • Circumferential thinning and • Fluorescein pooling but no staining abnormal blinking separated by clear zone increasing astigmatism • Mild thinning and vascularization• Formation of pseudo-pterygia if longstanding Treatment - lubricants and elimination of cause Treatment of severe astigmatism - crescent-shaped excision of gutter Mooren ulcer Peripheral corneal involvement in rheumatoid arthritis • Limited form - usually unilateral, affects elderly • Progressive form - bilateral, affects younger patients Without inflammation With inflammation Progression Peripheral ulcerative keratitisCircumferential and centralEnd-stage scarring and • Chronic and asymptomatic • Acute and painful spread vascularization • Circumferential thinning with intact • Circumferential ulceration and epithelium (‘contact lens cornea’) infiltration Treatment - systemic steroids and/or cytotoxic drugs Treatment - systemic steroids and/or cytotoxic drugs Peripheral corneal involvement in PERIPHERAL CORNEAL INFLAMMATION Wegener granulomatosis and polyarteritis nodosa 1. Marginal keratitis 2. Rosacea keratitis 3. Phlyctenulosis Circumferential and central Unlike Mooren ulcer sclera may also 4. Acute stromal keratitis ulceration similar to Mooren ulcer become involved Treatment - systemic steroids and cyclophosphamide Marginal keratitis Rosacea keratitis • Hypersensitivity reaction to Staph. exotoxins • Affects 5% of patients with acne rosaeca • May be associated with Staph. blepharitis • Bilateral and chronic • Unilateral, transient but recurrent Progression Progression Subepithelial infiltrate Circumferential spread Bridging vascularization Peripheral inferior Subepithelial infiltration Thinning and perforation separated by clear zone followed by resolution vascularization if severe Treatment - short course of topical steroids Treatment - topical steroids and systemic tetracycline or doxycyline Phlyctenulosis • Uncommon, unilateral - typically affects children CORNEAL INFECTIONS • Severe photophobia, lacrimation and blepharospasm 1. Bacterial keratitis Conjunctival phlycten Corneal phlycten 2. Fungal keratitis 3. Acanthamoeba keratitis 4. Infectious crystalline keratitis 5. Herpes simplex keratitis • Small pinkish-white nodule • Starts astride limbus -Epithelial near limbus • Resolves spontaneously or extends • Usually transient and resolves onto cornea -Disciform spontaneously Treatment - topical steroids 6. Herpes zoster keratitis Bacterial keratitis Fungal keratitis Predisposing factors Frequently preceded by ocular trauma with organic matter • Contact lens wear • Chronic ocular surface disease • Corneal hypoaesthesia Greyish-white ulcer which may be Slow progression and occasionally surrounded by feathery infiltrates hypopyon Treatment Expanding oval, yellow-white, Stromal suppuration and • Topical antifungal agents dense stromal infiltrate hypopyon • Systemic therapy if severe Treatment - topical ciprofloxacin 0.3% or ofloxacin 0.3% • Penetrating keratoplasty if unresponsive Acanthamoeba keratitis • Contact lens wearers at particular risk Infectious crystalline keratitis • Symptoms worse than signs • Very rare, indolent infection (Strep. viridans) • Usually associated with long-term topical steroid use • Particularly following penetrating keratoplasty Small, patchy anterior Perineural infiltrates stromal infiltrates (radial keratoneuritis) Ulceration, ring abscess Stromal opacification White, branching, anterior stromal crystalline deposits & small, satellite lesions Treatment - chlorhexidine or polyhexamethylenebiguanide Treatment - topical antibiotics Herpes simplex epithelial keratitis Herpes simplex disciform keratitis Signs Associations • Dendritic ulcer with terminal bulbs• May enlarge to become geographic • Stains with fluorescein Treatment • Central epithelial and stromal oedema • Occasionally surrounded by Wessely ring • Aciclovir 3% ointment x 5 daily • Folds in Descemet membrane • Trifluorothymidine 1% drops 2-hourly • Small keratic precipitates • Debridement if non-compliant Treatment - topical steroids with antiviral cover Herpes zoster keratitis Acute stromal keratitis Acute epithelial keratitis Nummular keratitis • Uncommon, usually unilateral • Associated with non-necrotizing scleritis Progression • Develops in about 50% within • Develops in about 30% within 2 days of rash 10 days of rash • Small, fine, dendritic or stellate• Multiple, fine, granular deposits epithelial lesions just beneath Bowman membrane • Tapered ends without bulbs • Halo of stromal haze Superficial or mid-stromal infiltration • Resolves within a few days • May become chronic Opacification and vascularization Treatment - topical steroids, if appropriate Treatment - topical steroids and systemic NSAIDs CORNEAL DEGENERATIONS Arcus senilis • Innocuous and extremely common in elderly 1. Age-related • Occasionally associated with hyperlipoproteinaemia • Arcus senilis • Vogt white limbal girdle • Crocodile shagreen • Cornea guttata 2. Lipid keratopathy • Primary • Secondary 3. Band keratopathy • Bilateral, circumferential bands • Peripheral border separated of lipid deposits from limbus by clear zone • 4. Spheroidal degeneration Diffuse central and sharp • Clear zone may be thinned peripheral border 5. Salzmann nodular degeneration ( senile furrow) Vogt white limbal girdle Crocodile shagreen • Innocuous and very common in elderly • Uncommon and innocuous • Usually bilateral • Bilateral • Polygonal stromal opacities separated by clear space • White, crescentic line along nasal and temporal • Most frequently involve anterior stroma limbus (anterior crocodile shagreen) • Type 1 - separated from limbus by clear zone • Occasionally involve posterior stroma • Type 2 - not separated by clear zone (posterior crocodile shagreen) Cornea guttata • Common, bilateral and usually innocuous Causes of Band Keratopathy • Rarely progression to Fuchs dystrophy 1. Ocular (common) • Chronic iridocyclitis, particularly in children • Associated with phthisis bulbi • Silicone oil in anterior chamber 2. Metabolic (rare) • Increased serum calcium and phosphorus • Hyperuricaemia • Chronic renal failure 3. Hereditary (rare) • Familial band keratopathy • Hereditary ichthyosis • Tiny dark spots on central endothelium • Similar peripheral lesions are Hassell-Henle bodies 4. Age-related (uncommon) Spheroidal degeneration Chelation of band keratopathy • Rare, typically affects outdoor workers • Starts with peripheral, interpalpebral, small amber-coloured granules in superficial stroma Progression Central spread, coalescence and Advanced lesions become opacification nodular and elevated Removal of corneal epithelium Application of sodium versenate Treatment • Debridement or superficial keratotomy if mild • Keratoplasty if severe Salzmann nodular degeneration Spheroidal degeneration • Uncommon, unilateral or bilateral • Rare, typically affects outdoor workers • Secondary to chronic keratitis • Starts with peripheral, interpalpebral, small amber-coloured granules in superficial stroma Progression Central spread, coalescence and Advanced lesions become • Discrete superficial stromal opacities opacification nodular and elevated and nodules Treatment • Base of nodule may be surrounded by iron deposits • Debridement or superficial keratotomy if mild Treatment - similar to spheroid degeneration • Keratoplasty if severe CORNEAL DYSTROPHIES Cogan microcystic dystrophy 1. Anterior • Most common of all dystrophies • Cogan microcystic • Neither familial nor progressive .. • Recurrent corneal erosions in about 10% of cases • Reis-Bucklers • Meesmann • Schnyder Dots Cysts 2. Stromal • Lattice I, II, III • Granular I, II, III (Avellino) • Macular 3. Posterior • Fuchs endothelial • Posterior polymorphous Fingerprints Maps Signs of Cogan dystrophy .. Four types of lesions - in isolation or combination Reis-Bucklers dystrophy Dots Microcysts Inheritance - autosomal dominant Onset - early childhood with recurrent corneal erosions Maps Fingerprints Superficial polygonal Honeycomb appearance opacities Treatment - keratoplasty if severe Meesmann dystrophy Schnyder dystrophy Inheritance - autosomal dominant Inheritance - autosomal dominant Onset - second decade with visual impairment Onset - first decade with mild visual symptoms • Tiny, epithelial cysts, maximal centrally • Clear in retroillumination • Grey in direct illumination Subepithelial ‘crystalline’ opacities Treatment - not required Treatment - excimer laser keratectomy Lattice dystrophy type I Lattice dystrophy type II Inheritance - autosomal dominant (Familial amyloidosis with lattice dystrophy, Meretoja syndrome) Onset - late first decade with recurrent corneal erosions Progression Inheritance Autosomal dominant Onset Middle age with progressive facial palsy and lattice dystrophy identical to type I Systemic features • Cranial and peripheral neuropathy • Skin laxity • Renal and cardiac failure Fine, spidery, branching lines within Later general haze may submerge stroma
Recommended publications
  • Update on Pathologic Diagnosis of Corneal Infections and Inflammations
    [Downloaded free from http://www.meajo.org on Tuesday, March 27, 2012, IP: 41.234.93.234] || Click here to download free Android application for this journal Eye Pathology Update Update on Pathologic Diagnosis of Corneal Infections and Inflammations Geeta K. Vemuganti, Somasheila I. Murthy1, Sujata Das2 ABSTRACT Access this article online Website: One of the most frequent types of corneal specimen that we received in our pathology laboratory www.meajo.org is an excised corneal tissue following keratoplasty. Several of these cases are due to corneal DOI: infections or the sequelae, like corneal scar. Advances in the histological and molecular 10.4103/0974-9233.90128 diagnosis of corneal infections and inflammations have resulted in rapid and accurate diagnosis Quick Response Code: of the infectious agent and in the overall understanding of the mechanisms in inflammatory diseases of the cornea. This review provides an update of histopathological findings in various corneal infections and inflammations. Key words: Corneal Histopathology, Corneal Infiltrate, Corneal Inflammations, Microbial Keratitis, Moorens’ Ulcer INTRODUCTION Corneal infections often commence as epithelial ulceration followed by stromal infiltration by polymorphonuclear (PMN) eratitis is an important cause of ocular morbidity worldwide, and lymphomononuclear cells leading to destruction of Bowman’s Kthe outcome of which depends on early diagnosis, prompt layer, stromal necrosis and perforation of the Descemet’s 1 and effective treatment and various host and agent factors. Some membrane in severe cases. Suppurative infections like bacterial of the common causes of infectious keratitis include bacterial, and fungal lead to infiltrates in anterior 2/3 of stroma and abscess fungal, viral, and protozoan, the diagnosis of which is made on formation.
    [Show full text]
  • Read PDF Edition
    REVIEW OF OPTOMETRY EARN 2 CE CREDITS: Positive Visual Phenomena—Etiologies Beyond the Eye, PAGE 58 ■ VOL. 155 NO. 1 January 15, 2018 www.reviewofoptometry.comwww.reviewofoptometry.com ■ ANNUAL CORNEA REPORT JANUARY 15, 2018 ■ CXL ■ EPITHELIAL DEFECTS How to Heal Persistent Epithelial Defects PAGE 38 ■ TRANSPLANTS Corneal Transplants: The OD’s Role PAGE 44 ■ INFILTRATES Diagnosing Corneal Infiltrative Disease PAGE 50 ■ POSITIVE VISUAL PHENOMENA CXL: Your Top 12 Questions —Answered! PAGE 30 001_ro0118_fc.indd 1 1/5/18 4:34 PM ĊčĞĉėĆęĊĉĆĒēĎĔęĎĈĒĊĒćėĆēĊċĔėĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊĘ ĊđĎĊċĎēĘĎČčę ċċĊĈęĎěĊ Ȉ 1 Ȉ 1 ĊđđǦęĔđĊėĆęĊĉ Ȉ Ȉ ĎĒĕđĊĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊ Ȉ Ȉ ĔēěĊēĎĊēę Ȉ͝ Ȉ Ȉ Ƭ 1 ǡ ǡǡǤ͚͙͘͜Ǥ Ȁ Ǥ ͚͙͘͜ǣ͘͘ǣ͘͘͘Ǧ͘͘͘ ĕĕđĎĈĆęĎĔēĘ Ȉ Ȉ Ȉ Ȉ Ȉ čĊĚėĎĔē̾ėĔĈĊĘĘ Ȉ Ȉ Katena — Your completecomplete resource forfor amniotic membrane pprocedurerocedure pproducts:roducts: Single use speculums Single use spears ͙͘͘ǡ͘͘͘ήĊĞĊĘęėĊĆęĊĉ Forceps ® ,#"EWB3FW XXXLBUFOBDPNr RO0118_Katena.indd 1 1/2/18 10:34 AM News Review VOL. 155 NO. 1 ■ JANUARY 15, 2018 IN THE NEWS Accelerated CXL Shows The FDA recently approved Luxturna (voretigene neparvovec-rzyl, Spark Promise—and Caution Therapeutics), a directly administered gene therapy that targets biallelic This new technology is already advancing, but not without RPE65 mutation-associated retinal dystrophy. The therapy is designed to some bumps in the road. deliver a normal copy of the gene to By Rebecca Hepp, Managing Editor retinal cells to restore vision loss. While the approval provides hope for patients, wo new studies highlight the resulted in infection—while tradi- the $425,000 per eye price tag stands as pros and cons of accelerated tional C-CXL has a reported inci- a signifi cant hurdle.
    [Show full text]
  • Anterior Segment Surgery and Complications CATARACT EXTRACTION and INTRAOCULAR LENS IMPLANTATION
    10 Anterior Segment Surgery and Complications CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION Complications PENETRATING KERATOPLASTY Complications Correction of Astigmatism in a Corneal Graft LAMELLAR KERATOPLASTY SUPERFICIAL KERATECTOMY EXCIMER LASER PHOTOTHERAPEUTIC KERATECTOMY CONJUNCTIVAL FLAP LIMBAL STEM CELL TRANSPLANTATION PTERYGIUM EXCISION AND CONJUNCTIVAL AUTOGRAFT CONJUNCTIVAL AND CORNEAL TUMOR EXCISION CORNEAL PERFORATION SURGERY PERMANENT KERATOPROSTHESIS REFRACTIVE SURGERY Radial Keratotomy Excimer Laser Photorefractive Keratectomy Laser In Situ Keratomileusis CONCLUSION Anterior segment surgery ranges from routine cataract extraction and lens implantation, one of the most common surgical operations in the United States, to rarely performed surgery such as permanent keratoprosthesis. It also encompasses surgery first performed centuries ago, such as rudimentary pterygium excision, to the latest in keratorefractive surgery. CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION The many reasons for the development of cataracts are discussed in detail in Chapter 8. Most cataracts are acquired, but they can also be congenital. This section focuses primarily on the treatment of acquired cataracts in adults. Cataracts in adults are generally age related, but some lens opacities may result from other causes such as trauma, inflammation, systemic illness such as diabetes, or medications such as corticosteroids. Cataracts generally advance slowly over years but can advance rapidly over months, or even faster in some patients. The primary indication for cataract extraction is diminished vision caused by the cataract, significantly affecting the patient's lifestyle. The exact point at which this hardship occurs depends on the patient. Certain patients require little visual function and may delay cataract surgery for years or indefinitely. Other patients with high visual needs seek cataract surgery with much smaller degrees of visual loss.
    [Show full text]
  • Cornea/External Disease 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Cornea/External Disease *** Cornea/External Disease 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • Ben Connell Totally Random Cases Handout
    Totally random: A recall of cases I’ve learnt from Dr Ben Connell FRANZCO MPH Eye Surgery Associates Melbourne Corneal Unit Royal Victorian Eye and Ear Hospital Ben Connell 1 Acknowledgements • ESA Orthoptists and administration staff No financial disclosures Ben Connell 2 Learning objectives 1. Diagnose a range of “once in a lifetime” conditions 2. Insights: condition that are easy to miss. Gain some awareness on what these conditions are (?learn from when Ben has done this) 3. Improve skills in managing patient expectations No financial disclosures Ben Connell 3 Q1: Contact lens wearer 21 year old contact lens wearer • 1 week of eye pain and headache • What is your diagnosis? 1. Microbial keratitis 2. Marginal keratitis 3. Acanthamoeba keratitis 4. HSV keratitis Ben Connell 4 Q2: Corneal changes 48 year old • PK for HSV, long term Flarex • Slight blur in vision • What is your diagnosis? 1. Microbial keratitis 2. Infectious crystalline keratopathy 3. HSV keratitis 4. Christmas eye Ben Connell 5 Q3: Microbial keratitis 23 year old • Contact lens wearer • Blurred vision Could I go blind doctor? 1. Yes 2. No Ben Connell 6 Q4: Contact lens related microbial keratitis Contact lens microbial keratitis • Which organism is least likely to cause this? 1. Staph Epidermidis 2. Staph Aureus 3. Pseudomonas 4. Streptococcus • Important to review day 1 • Will often get worse before better • Keratoplasty Ben Connell 7 Commonest micro report Ben Connell 8 Microbial keratitis What are your exam findings? Ben Connell 9 Q5: What is your diagnosis? 28 yo Woman • Rings around lights when night driving • A bit red a few weeks ago • Son has sore throat What is your diagnosis? 1.
    [Show full text]
  • Cornea/External Disease 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Cornea/External Disease *** Cornea/External Disease 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • New and Emerging Approaches to Ocular Surface Inflammation
    MEDICAL ED NG UC UI AT A CONTINUING TIN IO CON N MEDICAL EDUCATION PUBLICATION CME ISSUE 20 New and Emerging Approaches to Ocular Surface In ammation A STEPHEN PFLUGFELDER, MD The immune zyme, and immunoglobu- environment of the ocular surface o ers multiple lins, which exert antimicro- opportunities for pharmaceutical intervention. bial and antiinflammatory Following the exa mple of other medical specialties, eff ects.1 Transmembrane and ophthalmologists are likely to see an in ux of more secreted mucins are released targeted therapies for ocular surface in ammation. in response to foreign, nox- ious, or antigenic stimuli. B Secreted mucins (such as Under normal circumstances, complex, tightly woven MUC5AC and MUC7) may immune mechanisms on the ocular surface keep the eye safe participate in defense by from invasion or insult. A certain level of transient, physi- preventing pathogen bind- ological infl ammation is a necessary part of this operation, ing or by surrounding and dominated by the elements of the innate or intrinsic immune removing contaminants.2 FIGURE 1 A. Neovascularization and system. Infl ammation becomes pathological when these same Resident immune cells like infi ltrates in a 13-year-old patient elements become dysregulated, as in autoimmune or chronic macrophages deal with ocu- with chronic recurrent blepharitis infl ammatory conditions, and go from being protective to and marginal keratitis. B. Regression lar surface invasion in rela- of corneal neovascularization after 1 damaging of host ocular surface tissues. tively nonspecifi c ways, but month of topical corticosteroid. (Images Treating pathological infl ammation always carries the risk do have pattern-recognition courtesy of Dr.
    [Show full text]
  • Repeat Penetrating Keratoplasty: Indications and Prognosis, 1995-2005
    European Journal of Ophthalmology / Vol. 19 no. 3, 2009 / pp. 362-368 Repeat penetrating keratoplasty: indications and prognosis, 1995-2005 ZULEYHA YALNIZ-AKKAYA, AYSE BURCU NUROZLER, ELVIN HATICE YILDIZ, MUSTAFA ONAT, KORAY BUDAK, SUNAY DUMAN Department of Ophthalmology, Ankara Training and Research Hospital, Ankara - Turkey PURPOSE. To evaluate the data of penetrating keratoplasty over a 10-year period and to com- pare indications and outcomes of eyes undergoing single graft with those of eyes requiring re- grafting. METHODS. A total of 652 eyes of 613 patients required single graft (Group I). Sixty-one regrafts were performed on 53 eyes (Group II). The mean follow-up time was 23.4±21.3 months (range 6–132 months). The results were evaluated for the following criteria: primary indications, allo- graft reactions, graft clarity, final postoperative visual acuity, and complications leading to re- duction in vision. RESULTS. The most common indication was keratoconus (228 eyes; 35.0%) in Group I, and vas- cularized corneal scar (12 eyes; 22.6%) in Group II. Allograft reactions occurred in 96 eyes (14.7%) in Group I, and 17 eyes (32.0%) in Group II (p=0.001). At the end of the study period, 76.4% of patients in Group I had entirely clear grafts, whereas 45.3% of patients in Group II had entirely clear grafts (p=0.000). The main causes of corneal graft failure were irreversible allograft reaction, endothelial failure, and graft infection, which were all seen in higher per- centage in the regraft group. A best-corrected visual acuity of 20/100 or better was achieved in 377 eyes (57.8%) in Group I and 11 eyes (20.7%) in Group II (p=0.000).
    [Show full text]
  • Associated with Congenital Glaucoma: ?
    1 For each statement, identify with which it is associated: Q Horizontal corneal lines, or Vertical corneal lines Associated with congenital glaucoma: ? V ertical Horizontal 2 For each statement, identify with which it is associated: A Horizontal corneal lines, or Vertical corneal lines Associated with congenital glaucoma: Horizontal ertical orizontal V High IOP 3 For each statement, identify with which it is associated: Q Horizontal corneal lines, or Vertical corneal lines Associated with congenital glaucoma: Horizontal What is the name for the horizontal corneal finding associated with congenital glaucoma? Haab striae What do Haab striae look like? A pair of parallel lines that taper and meet at their ends Haab striae represent what sort of pathology, ie, which corneal structure is damaged, and in what way? Tears in Descemet’s secondary to corneal stretching What is the mechanism? Mechanical deformation caused by the elevated IOP ertical orizontal V High IOP 4 For each statement, identify with which it is associated: A Horizontal corneal lines, or Vertical corneal lines Associated with congenital glaucoma: Horizontal What is the name for the horizontal corneal finding associated with congenital glaucoma? Haab striae What do Haab striae look like? A pair of parallel lines that taper and meet at their ends Haab striae represent what sort of pathology, ie, which corneal structure is damaged, and in what way? Tears in Descemet’s secondary to corneal stretching What is the mechanism? Mechanical deformation caused by the elevated IOP
    [Show full text]
  • June 2018 Examination
    June 2018 Examination 1 CLINICAL MANAGEMENT GUIDELINES Atopic Keratoconjunctivitis (AKC) Aetiology Severe ocular surface disease affecting some atopic individuals Complex immunopathology Sometimes follows childhood Vernal Keratoconjunctivitis (VKC) (see Clinical Management Guideline on Vernal Keratoconjunctivitis) Predisposing factors Typically affects young adult atopic males There may be a history of asthma, hay fever, eczema and VKC in childhood Most patients have atopic dermatitis affecting the eyelids and periorbital skin There is a strong association with staphylococcal lid margin disease Specific allergens may exacerbate the condition Symptoms Ocular itching, watering, usually bilateral Blurred vision, photophobia White stringy mucoid discharge Onset of ocular symptoms may occur several years after onset of atopy Symptoms usually year-round, with exacerbations Signs Eyelids may be thickened, crusted and fissured Associated chronic staphylococcal blepharitis Tarsal conjunctiva: giant papillary hypertrophy, subepithelial scarring and shrinkage Entire conjunctiva hyperaemic Limbal inflammation Corneal involvement is common and may be sight-threatening: beginning with punctate epitheliopathy that may progress to macro-erosion, plaque formation (usually upper half), progressive corneal subepithelial scarring, neovascularisation, thinning, and rarely spontaneous perforation These patients are prone to develop herpes simplex keratitis (which may be bilateral), corneal ectasia such as keratoconus, atopic (anterior or posterior polar) cataracts,
    [Show full text]
  • Intraocular Surgery Following Penetrating Keratoplasty: the Risks and Advantages
    Eye (1990) 4, 693-697 Intraocular Surgery Following Penetrating Keratoplasty: The Risks and Advantages L. A. FICKER, C. M. KIRKNESS, A. D. McG STEELE, N. S. C. RICE, A. M. E. GILVARRY London Summary Graft survival has been evaluated for patients who underwent subsequent intra­ ocular surgery (extra-capsular cataract surgery or trabeculectomy) between 1983 and 1989. The patients were different from the majority of keratoplasty patients as evidenced by the indications for keratoplasty; corneal perforation was the indication in 24% of cases. Perforated and inflamed eyes were treated aggressively at the time of the acute event, including emergency keratoplasty and intensive topical steroids. Visco-elastic fluids were routinely used during secondary surgery and topical ste­ roids were administered intensively post-operatively. The incidence of post-oper­ ative graft rejection was low (less than 14%). Rejection episodes were diagnosed early, prior to the appearance of a Khodadoust line, and were treated aggressively with intensive topical steroids. Glaucoma which was not controlled by topical ther­ apy was surgically managed by trabeculectomy in the first instance. If this failed, tube drainage was performed and long-term topical steroids were administered. The only risk factor identified was uncontrolled glaucoma, P=O.1. The probability of graft survival (at five years) was 0.83 after cataract surgery and 0.62 after trabecu­ lectomy, but wide confidence limits indicate the difference is not significant. The impact of intraocular surgery upon a pre­ For patients in whom corneal disease co­ existing penetrating keratoplasty (PK) is per­ exists with early cataract there are advantages tinent to various sub-groups of patients with in deferring cataract surgery in patients corneal disease.
    [Show full text]
  • Management of Cytomegalovirus Corneal Endotheliitis Angela H
    Wong et al. Eye and Vision (2021) 8:3 https://doi.org/10.1186/s40662-020-00226-y REVIEW Open Access Management of cytomegalovirus corneal endotheliitis Angela H. Y. Wong1, Wee Nie Kua1, Alvin L. Young2,3 and Kelvin H. Wan3* Abstract Background: Cytomegalovirus (CMV) can manifest as corneal endotheliitis in immunocompetent individuals. Early diagnosis is prudent to prevent endothelial cell loss, which could ultimately lead to corneal decompensation. CMV DNA was first detected in an eye with corneal endotheliitis in 2006; since then, clinical evidence from numerous case reports and case series have accumulated. Main text: In this narrative review, we identified several drugs, including ganciclovir, valganciclovir, and their combination in oral, intravenous, intravitreal, and topical forms in different concentrations, together with the judicious use of topical steroids, have reported variable success. There has yet to be any prospective comparative study evaluating the efficacy and safety of these assorted forms of treatment; clinical evidence is based on case reports and case series. CMV endotheliitis presenting with corneal edema can masquerade as other corneal diseases and thus poses a great challenge especially in post-keratoplasty eyes. Heightened awareness is needed before and after keratoplasty to start prompt prophylaxis and treatment. Conclusion: There is no consensus on the management of CMV endotheliitis. Further studies are much needed to elucidate the optimal treatment modality, regime, and duration in the treatment and prophylaxis
    [Show full text]